NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $388 | -24.4% | 20,200 | 0.0% | 0.08% | -21.2% |
| Q2 2023 | $513 | +7.5% | 20,200 | +53.0% | 0.10% | -1.0% |
| Q1 2023 | $477 | -45.2% | 13,200 | -40.0% | 0.10% | -49.5% |
| Q4 2022 | $871 | -99.9% | 22,000 | 0.0% | 0.21% | -20.0% |
| Q3 2022 | $1,025,000 | -13.4% | 22,000 | -18.5% | 0.26% | -8.1% |
| Q2 2022 | $1,183,000 | -22.1% | 27,000 | +28.6% | 0.28% | -5.0% |
| Q1 2022 | $1,519,000 | +623.3% | 21,000 | +288.9% | 0.30% | +292.1% |
| Q4 2018 | $210,000 | +4.0% | 5,400 | +52.1% | 0.08% | +20.6% |
| Q3 2018 | $202,000 | -68.7% | 3,550 | -69.0% | 0.06% | -81.8% |
| Q1 2016 | $645,000 | -16.1% | 11,459 | +0.7% | 0.35% | -18.2% |
| Q4 2015 | $769,000 | – | 11,384 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |